iifl-logo-icon 1

Natco Pharma Ltd Historical Data

780.85
(-0.39%)
Mar 13, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Natco Pharma Ltd Historical Data

15/02/2025calendar-icon
15/03/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

12-Feb-2025

1,242

1,2451,185.151,218.861,57166,26,48,386.31,96,267

13-Feb-2025

1,039.1

1,051.25975.05975.052,63,6538,40,10,90,194.529,03,178

14-Feb-2025

950

950867.6883.23,61,4177,27,47,85,420.6518,40,699

17-Feb-2025

880

903.15861.9870.4552,0461,33,84,69,650.25,61,560

18-Feb-2025

876

884.35822834.5558,3861,14,19,79,109.855,53,913

19-Feb-2025

824.25

853.9808.681358,04691,80,23,007.254,44,926

20-Feb-2025

812.8

821.85790.6793.1572,4241,20,47,79,456.657,38,635

21-Feb-2025

792

816778.3797.9561,1701,28,39,55,310.37,30,195

24-Feb-2025

790.1

844.9775.6823.164,0121,83,53,09,9056,46,627

25-Feb-2025

829.85

849.75817821.940,60577,15,44,139.353,17,983

27-Feb-2025

833.75

834.4783.6796.7540,89969,99,72,310.954,19,492

28-Feb-2025

783.1

792.9757.05770.760,3541,22,50,27,149.28,29,650

03-Mar-2025

776.75

804.9776.75795.6566,4941,19,84,59,877.653,66,497

04-Mar-2025

791.6

814.9780.4802.8535,46974,26,67,219.953,58,093

05-Mar-2025

802.85

826.6793.8819.8559,22786,29,35,404.454,29,358

06-Mar-2025

825.25

847.05821.1582336,93164,30,19,872.853,81,603

07-Mar-2025

825

829.5812.8582529,06141,54,57,949.652,22,820

10-Mar-2025

828.95

831.85806.3811.529,66344,98,94,771.13,37,920

11-Mar-2025

796

806.25784.7788.0567,01384,56,23,348.256,37,620

12-Mar-2025

795.05

804.95780783.932,03236,34,28,708.852,82,360

13-Mar-2025

786.55

797779.9780.8529,97347,26,22,698.23,70,684

Natco Pharma: Related NEWS

Natco Pharma Gets USFDA Approval for Bosentan 32mg Tablets
12 Feb 2025|11:14 AM

The drug enhances the flow of blood through the lungs, allowing children with PAH to breathe and improve their ability to engage in physical activity.

Read More
Natco Pharma Sells Telangana Land for ₹115.57 Crore
1 Dec 2024|07:16 PM

The company was ensured that the sale of the land and building did not constitute part of its operational assets so that the sale will, in no way, impact the company's business operations

Read More
Natco Pharma Q2 Profit Surges 83%, Declares Interim Dividend
12 Nov 2024|10:26 PM

The revenue for the September quarter rose by 33% to ₹1,371 crore from ₹1,031 crore in the corresponding period last year.

Read More
Natco Pharma settles US patent case over generic Ozempic
7 Oct 2024|01:52 PM

According to data from the BSE index, the stock has achieved multibagger gains over the last two years, climbing 122.04%.

Read More
Cancer Patients Benefit as GST on Medications Slashed
10 Sep 2024|12:22 PM

The plan to reduce the GST on these drugs aims to significantly reduce the overall cost of cancer treatment.

Read More
Natco Pharma invests $8 million in US biotech firm eGenesis
4 Sep 2024|03:28 PM

Natco Pharma disclosed that its subsidiary will invest USD 8 million in eGenesis, acquiring a total of 40,629,761 shares.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.